Literature DB >> 35291539

Atypical Stevens-Johnson Syndrome Associated With Mycoplasma Pneumoniae.

Ramin Beheshti1, Bryan Cusack1.   

Abstract

Mycoplasma pneumoniae primarily causes atypical pneumonia in children and young adults. 7%-8% of patients with M. pneumoniae infections may experience extra-pulmonary manifestations, including M. pneumoniae-associated Stevens-Johnson Syndrome (SJS), also known as atypical SJS. In recent literature, there have been a few reports of isolated mucositis in children with M. pneumoniae infections. Due to significant overlap with several diseases, including autoimmune disease and infections, atypical mucositis associated with M. pneumoniae is often a diagnostic challenge. In addition, due to limited cases of M. pneumoniae-associated SJS, there is no established standardized treatment guideline that has been shown to reduce hospitalization duration and/or disease progression associated with M. pneumoniae-associated SJS. We report a case of isolated mucositis in the absence of cutaneous involvement in a 10-year-old patient with an acute M. pneumoniae infection. Examination revealed erythematous ulcerations of his lips and pharynx with patchy exudates and bilateral submandibular lymphadenopathy. Laboratory investigation revealed a negative respiratory polymerase chain reaction (PCR) panel, which included M. pneumoniae. Further testing revealed a positive M. pneumoniae immunoglobulin M (IgM) titer on enzyme immunoassay. The diagnosis of atypical SJS was made secondary to M. pneumoniae. Treatment was initiated with systemic steroids and oral antibiotics. Limitations in diagnostic testing for M. pneumoniae in combination with non-specific clinical presentation make for challenges in confirming this pattern of SJS due to a primary M. pneumoniae infection. In this case, serological testing confirmed our suspected diagnosis, which guided treatment and helped reveal some of the difficulties in diagnosing and managing M. pneumoniae-associated SJS.
Copyright © 2022, Beheshti et al.

Entities:  

Keywords:  atypical rash; delayed diagnosis; diagnostic medicine; mycoplasma pneumonia; steven johnson syndrome

Year:  2022        PMID: 35291539      PMCID: PMC8896837          DOI: 10.7759/cureus.21825

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Detection of Mycoplasma in cell cultures.

Authors:  Lesley Young; Julia Sung; Glyn Stacey; John R Masters
Journal:  Nat Protoc       Date:  2010-04-22       Impact factor: 13.491

2.  Stevens-Johnson syndrome without skin lesions.

Authors:  K Latsch; H J Girschick; M Abele-Horn
Journal:  J Med Microbiol       Date:  2007-12       Impact factor: 2.472

Review 3.  Mycoplasma pneumoniae-induced cutaneous disease.

Authors:  Peter C Schalock; James G H Dinulos
Journal:  Int J Dermatol       Date:  2009-07       Impact factor: 2.736

4.  Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome.

Authors:  C Léauté-Labrèze; T Lamireau; D Chawki; J Maleville; A Taïeb
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

5.  Extracutaneous manifestations and long-term sequelae of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  A Vercueil; S Walsh
Journal:  Br J Dermatol       Date:  2015-02       Impact factor: 9.302

6.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Authors:  Noel Frey; Michael Bodmer; Andreas Bircher; Susan S Jick; Christoph R Meier; Julia Spoendlin
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

7.  Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.

Authors:  Caroline J Catt; Gavin M Hamilton; Joel Fish; Kamiar Mireskandari; Asim Ali
Journal:  Am J Ophthalmol       Date:  2016-03-24       Impact factor: 5.258

8.  Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.

Authors:  M-C Brüggen; S T Le; S Walsh; A Toussi; N de Prost; A Ranki; B Didona; A Colin; B Horváth; E Brezinova; B Milpied; C Moss; C Bodemer; D Meyersburg; C Salavastru; G-S Tiplica; E Howard; E Bequignon; J N Bouwes Bavinck; J Newman; J Gueudry; M Nägeli; K Zaghbib; K Pallesen; A Bygum; P Joly; P Wolkenstein; S-L Chua; R Le Floch; N H Shear; C-Y Chu; N Hama; R Abe; W-H Chung; T Shiohara; M Ardern-Jones; P Romanelli; E J Phillips; R S Stern; J Cotliar; R G Micheletti; A Brassard; J T Schulz; R P Dodiuk-Gad; A R Dominguez; A S Paller; L Seminario-Vidal; A Mostaghimi; M H Noe; S Worswick; D Tartar; R Sheridan; B H Kaffenberger; K Shinkai; E Maverakis; L E French; S Ingen-Housz-Oro
Journal:  Br J Dermatol       Date:  2021-03-03       Impact factor: 9.302

9.  Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series.

Authors:  Karen A Ravin; Lara D Rappaport; Noel S Zuckerbraun; Robert M Wadowsky; Ellen R Wald; Marian M Michaels
Journal:  Pediatrics       Date:  2007-03-12       Impact factor: 7.124

Review 10.  Mycoplasma pneumoniae infections.

Authors:  M R Hammerschlag
Journal:  Curr Opin Infect Dis       Date:  2001-04       Impact factor: 4.915

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.